Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABUS · against 483 other Healthcare companies of similar size
Ranked #27 of 484 · scores higher than 95% of peers · safety percentile 95
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)54 peers with a safety percentile of 90–100, including ABUS · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ABUS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 451 reported | 0.01× | 0.17× | 85% | 33% | |
| BetaLower is better · 460 reported | 0.76 | 0.41 | 31% | 33% | |
| Current ratioHigher is better · 478 reported | 81.42× | 2.90× | 100% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.2B USD | 100 | 40 | |
| 2 | 1.1B USD | 100 | ||
| 3 | 1.0B USD | 99 | 35 | |
| 4 | 421M USD | 99 | 52 | |
| 5 | 1.2B USD | 99 | ||
| 23 | 71.0B JPY (≈$483M) | 96 | ||
| 24 | 389M USD | 96 | 33 | |
| 25 | 2.4B CNY (≈$331M) | 96 | 51 | |
| 26 | 647M USD | 95 | 40 | |
| 27 | 595M USD | 95 | 97 | |
| 28 | 365M USD | 95 | 41 | |
| 29 | 593M USD | 95 | 40 | |
| 30 | 6.3B CNY (≈$878M) | 95 | 32 | |
| 31 | 3.2B CNY (≈$449M) | 95 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score